List of Excipients in API BUTENAFINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BUTENAFINE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mylan Pharmaceuticals Inc | MENTAX | butenafine hydrochloride | 0378-6151 | BENZYL ALCOHOL | |
| Mylan Pharmaceuticals Inc | MENTAX | butenafine hydrochloride | 0378-6151 | CETYL ALCOHOL | |
| Mylan Pharmaceuticals Inc | MENTAX | butenafine hydrochloride | 0378-6151 | DIETHANOLAMINE | |
| Mylan Pharmaceuticals Inc | MENTAX | butenafine hydrochloride | 0378-6151 | GLYCERIN | |
| Mylan Pharmaceuticals Inc | MENTAX | butenafine hydrochloride | 0378-6151 | GLYCERYL MONOSTEARATE | |
| Mylan Pharmaceuticals Inc | MENTAX | butenafine hydrochloride | 0378-6151 | PETROLATUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BUTENAFINE HYDROCHLORIDE
Detailed excipient profiles for BUTENAFINE HYDROCHLORIDE
Excipient focus: BENZYL ALCOHOL
BUTENAFINE HYDROCHLORIDE drug variants containing BENZYL ALCOHOL
BUTENAFINE HYDROCHLORIDE drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETETH-23
BUTENAFINE HYDROCHLORIDE drug variants containing CETETH-23
BUTENAFINE HYDROCHLORIDE drug variants not containing CETETH-23
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | butenafine hydrochloride | 0378-6151 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
BUTENAFINE HYDROCHLORIDE drug variants containing CETYL ALCOHOL
BUTENAFINE HYDROCHLORIDE drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHANOLAMINE
BUTENAFINE HYDROCHLORIDE drug variants containing DIETHANOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | butenafine hydrochloride | 0378-6151 |
| Bayer HealthCare LLC | butenafine hydrochloride | 11523-7154 |
| Bayer HealthCare LLC | butenafine hydrochloride | 11523-7155 |
| >Company | >Ingredient | >NDC |
BUTENAFINE HYDROCHLORIDE drug variants not containing DIETHANOLAMINE
Excipient focus: GLYCERIN
BUTENAFINE HYDROCHLORIDE drug variants containing GLYCERIN
BUTENAFINE HYDROCHLORIDE drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
BUTENAFINE HYDROCHLORIDE drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | butenafine hydrochloride | 0378-6151 |
| Bayer Healthcare LLC | butenafine hydrochloride | 11523-0082 |
| Bayer Healthcare LLC | butenafine hydrochloride | 11523-4339 |
| >Company | >Ingredient | >NDC |
BUTENAFINE HYDROCHLORIDE drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: GLYCERYL STEARATE SE
BUTENAFINE HYDROCHLORIDE drug variants containing GLYCERYL STEARATE SE
BUTENAFINE HYDROCHLORIDE drug variants not containing GLYCERYL STEARATE SE
Excipient focus: PETROLATUM
BUTENAFINE HYDROCHLORIDE drug variants containing PETROLATUM
BUTENAFINE HYDROCHLORIDE drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Walgreen Company | butenafine hydrochloride | 0363-2100 |
| Bayer Healthcare LLC | butenafine hydrochloride | 11523-0082 |
| Rite Aid Corporation | butenafine hydrochloride | 11822-2100 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
BUTENAFINE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | butenafine hydrochloride | 0378-6151 |
| >Company | >Ingredient | >NDC |
BUTENAFINE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLENE GLYCOL DICAPRYLATE
BUTENAFINE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL DICAPRYLATE
BUTENAFINE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL DICAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | butenafine hydrochloride | 0378-6151 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
BUTENAFINE HYDROCHLORIDE drug variants containing SODIUM BENZOATE
BUTENAFINE HYDROCHLORIDE drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
BUTENAFINE HYDROCHLORIDE drug variants containing STEARIC ACID
BUTENAFINE HYDROCHLORIDE drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TROLAMINE
BUTENAFINE HYDROCHLORIDE drug variants containing TROLAMINE
BUTENAFINE HYDROCHLORIDE drug variants not containing TROLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | butenafine hydrochloride | 0378-6151 |
| Bayer HealthCare LLC | butenafine hydrochloride | 11523-7154 |
| Bayer HealthCare LLC | butenafine hydrochloride | 11523-7155 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
BUTENAFINE HYDROCHLORIDE drug variants containing WATER
BUTENAFINE HYDROCHLORIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
BUTENAFINE HYDROCHLORIDE drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Bayer Healthcare LLC | butenafine hydrochloride | 11523-0082 |
| >Company | >Ingredient | >NDC |
BUTENAFINE HYDROCHLORIDE drug variants not containing WHITE PETROLATUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
